Results 21 to 30 of about 312,772 (298)

Allergen Immunotherapy in Asthma

Pathogens, 2021
Allergen immunotherapy (AIT) is a specific treatment involving the administration of relevant allergens to allergic patients, with subtypes including subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
Kazuyuki Nakagome, Makoto Nagata
doaj   +1 more source

Evaluation of subcutaneous proleukin (Interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants [PDF]

, 2006
Background: ESPRIT, is a phase III, open-label, randomized, international clinical trial evaluating the effects of subcutaneous recombinant interleukin-2 (rIL-2) plus antiretroviral therapy (ART) versus ART alone on HIV-disease progression and death in ...
Tambussi, G., Tambussi, G, Law, MG, Law, M.G, ESPRIT Research Group, Pereira, LC, Pereira, L.C., Lopez, JC, Knysz, B, Lopez, J. C., Arduino, R., Pett, S.L., Reiss, P, Pollack, S., Arduino, R, Pett, S. L., Lopez, J.C., Wand, H, Knysz, B., Pereira, L. C., Wand, H., Emery, Sean, Law, M. G., Pollack, S, Reiss, P., Pett, SL, Mallal, S.   +26 more
core   +1 more source

New modalities of allergen immunotherapy

Human Vaccines & Immunotherapeutics, 2018
Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and ...
Manish Ramesh, Merhunisa Karagic
doaj   +1 more source

Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms [PDF]

, 2002
Background: Severe allergic reactions during rush-specific immunotherapy (Rush-SIT) may occur in the treatment of hymenoptera sting allergy. The objective of the present study was to examine the characteristics of allergic reactions during Rush-SIT in a ...
Mingomataj, Ervin, Fischer, Axel, Qirko, Etleva, Peiser, Christian, Groneberg, Jan David Alexander, Priftanji, Alfred, Dinh, Q. Thai   +6 more
core   +1 more source

Hypoallergenic molecules for subcutaneous immunotherapy

Expert Review of Clinical Immunology, 2015
Although a large part of the population suffers from allergies, a cure is not yet available. Allergen-specific immunotherapy (AIT) offers promise for these patients. AIT has proven successful in insect and venom allergies; however, for food allergy this is still unclear.
Jongejan, Laurian, van Ree, Ronald, Poulsen, Lars K   +2 more
openaire   +3 more sources

Subcutaneous immunotherapy in patients with eosinophilic esophagitis [PDF]

Annals of Allergy, Asthma & Immunology, 2019
Potential competing interests Dr. Dellon is a consultant for Adare, Alivio, Allakos, Banner, Calypso, Enumeral, EsoCap, GSK, Gossamer Bio, Receptos/Celegene, Regeneron, Robarts, and Shire, receives research funding from Allakos, Adare, GSK, Meritage, Miraca, Nutricia, Receptos/Celgene, Regeneron, and Shire, and has received an educational grant from ...
Benjamin S, Robey, Swathi, Eluri, Craig C, Reed, Maya R, Jerath, Michelle L, Hernandez, Scott P, Commins, Evan S, Dellon   +6 more
openaire   +2 more sources

Efficacy of subcutaneous immunotherapy achieved with a whole-body extract of Pseudomyrmex ant. A case reported in a young woman, in Argentina [PDF]

, 2018
The aim of this work is to report for the first time a patient case with anaphylaxis by Pseudomyrmex acanthobius /favidulus ant sting, prepare an extract with the wholeant-body, to study their biochemical and immunological properties and to validate the ...
Rodríguez Rodríguez, Raquel Milagros, Olgiati, María Laura, Mouchian, Krikor, Alonso, Angel, Irañeta, Silvia G., Duschak, Vilma Gladys, Soprano, Luciana Lía   +6 more
core   +1 more source

Clinical effectiveness of hymenoptera venom immunotherapy [PDF]

, 2013
Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors. Our aim was to evaluate the association of baseline serum tryptase concentration (BTC) and of other parameters with the frequency of VIT failure during ...
Scheipl, Fabian, Darsow, Ulf, Reider, Norbert, Bonifazi, Floriano, Aberer, Werner, Schmid-Grendelmeier, Peter, Ruëff, Franziska, Treudler, Regina, Biló, Maria Beatrice, Sturm, Gunter Johannes, Küchenhoff, Helmut, Severino, Maurizio, Wüthrich, Brunello, Seitz, Michael J., Quercia, Oliviero, Bodzenta-Lukaszyk, Anna, Lang, Roland, Haeberli, Gabrielle, Campi, Paolo, Hawranek, Thomas, Müller, Ulrich, Przybilla, Bernhard   +21 more
core   +1 more source

Future modalities in allergen immunotherapy: A brief overview

Indian Journal of Allergy Asthma and Immunology, 2018
Allergen immunotherapy (AIT) is the only disease-modifying modality for the treatment of allergic diseases. The well-known and approved formulations are subcutaneous immunotherapy (SCIT), sublingual immunotherapy (SLIT) and allergoids.
S N Gaur
doaj   +1 more source

Aluminium in allergen-specific subcutaneous immunotherapy – A German perspective [PDF]

, 2014
We are living in an “aluminium age” with increasing bioavailability of the metal for approximately 125 years, contributing significantly to the aluminium body burden of humans. Over the course of life, aluminium accumulates and is stored predominantly in
Kramer, Matthias F., Heath, Matthew D.
core   +1 more source